Thomas Schinecker
Thomas Schinecker Dr | |
|---|---|
| Born | April 23, 1975[1] |
| Nationality | Austria |
| Citizenship | Austrian, German |
| Education | University of Salzburg New York University |
| Occupation | CEO of Roche |
| Children | 3 |
Dr. Thomas Schinecker (born April 23, 1975 in Simbach am Inn) is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group.[2][3][4]
Early life
[edit]Schinecker was born to an Austrian father and German mother in Simbach am Inn, Germany.[5] From the age of nine, he grew up in Singapore as the son of an ABB employee, and attended the German school.[6][7] At the age of 19, he began studying genetics at the University of Salzburg, graduating with a bachelor's degree in 1997. He then continued his studies as a molecular biologist at New York University where he received his M.S in 2000 and Ph.D. in 2003.[8][9][10]
Career
[edit]In 2003, Schinecker joined the Roche Group as a management trainee working in the Roche diagnostics division in several countries.[11]
In 2005, he transitioned to the diagnostics field and assumed the position of Head of Marketing and Sales for Roche Diagnostics in Austria.[12] Subsequently, he held the role of General Manager for Roche Diagnostics in Sweden, followed by a two-year tenure in the United States. Later, he became the General Manager of Roche Diagnostics in Germany.[13] He was appointed CEO Roche Diagnostics in Rotkreuz, Switzerland in 2019.[14] Schinecker is known for leading the company's COVID-19 test kit efforts as the CEO of the Roche Diagnostics division.[15][16][17][18]
In January 2023, he served ad-interim as CEO Roche Pharmaceuticals before taking on the position of CEO full-time in March 2023, succeeding Severin Schwan.[19][20]
Memberships
[edit]Schinecker is a member of the Innovation Board of Labor Berlin (Charité and Vivantes).[21]
Since 2022, Schinecker serves as Vice-President of IFPMA. In November 2024, IFPMA announced that Schinecker would replace Albert Bourla as President.[22]
Personal life
[edit]Schinecker is married and has three children. The family has lived in Rotkreuz, Switzerland since 2017. He plays basketball, volleyball and squash.[6][23]
References
[edit]- ^ "Curriculum Vitae" (PDF). Retrieved 24 April 2023.
- ^ "Roche's chief executive to step down and become chair". Financial Times. 2022-07-21. Archived from the original on 2023-04-25. Retrieved 2023-04-25.
- ^ OLOF-ORS, Nathalie. "Roche Set For Shake-up At The Top". www.barrons.com. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
- ^ "Pharma: Der neue CEO Thomas Schinecker muss Roche wieder vorwärtsbringen". Handelszeitung (in Swiss High German). Archived from the original on 2023-04-02. Retrieved 2023-05-30.
- ^ "Schinecker folgt Redmann". www.mannheimer-morgen.de (in German). 2013-07-02. Retrieved 2024-08-12.
- ^ a b "Interview mit neuem Roche-Chef – "Wir werden dieses Jahr mehr in Forschung und Entwicklung investieren"". Tages-Anzeiger (in German). 15 March 2023. Archived from the original on 2023-04-25. Retrieved 2023-04-25.
- ^ Eric Nolmans: Roche-CEO Thomas Schinecker will im laufenden Jahr 15 Milliarden in die Forschung stecken. Archived 2023-04-02 at the Wayback Machine In: Bilanz. Nr. 4, 2023, S. 54–60.
- ^ "Curriculum Vitae" (PDF). Archived (PDF) from the original on 2023-05-15. Retrieved 2023-04-24.
- ^ "Auf den stillen Schaffer Thomas Schinecker warten bei Roche grosse Aufgaben". Neue Zürcher Zeitung.
- ^ Feldges, Dominik (2023-03-14). "Auf den stillen Schaffer Thomas Schinecker warten bei Roche grosse Aufgaben". Neue Züricher Zeitung. Retrieved 2023-05-30.
- ^ Roche Diagnostics CEO: GenMark deal will further expand global reach, archived from the original on 2023-05-30, retrieved 2023-05-30
- ^ Eric Nolmans: Roche-CEO Thomas Schinecker will im laufenden Jahr 15 Milliarden in die Forschung stecken. Archived 2023-04-02 at the Wayback Machine In: Bilanz. Nr. 4, 2023, S. 54–60.
- ^ "Roche | Dr. Thomas Schinecker". www.roche.com (in German). Archived from the original on 2024-07-19. Retrieved 2024-08-12.
- ^ "Roche promotes point-of-care head Schinecker to diagnostics CEO". Fiercebiotech. Archived from the original on 2024-08-12. Retrieved 2024-08-12.
- ^ Burger, Ludwig (2022-07-21). "Roche diagnostics head to take helm of Swiss pharma giant". Reuters. Archived from the original on 2023-04-24. Retrieved 2023-04-24.
- ^ swissinfo.ch/jdp (26 December 2021). "Roche at-home Covid tests receive US FDA nod". SWI swissinfo.ch. Archived from the original on 2023-04-24. Retrieved 2023-04-24.
- ^ Weiland, Noah; Thomas, Katie (2020-03-13). "Trump Administration Moves to Speed Coronavirus Testing". The New York Times. ISSN 0362-4331. Archived from the original on 2023-04-23. Retrieved 2023-04-24.
- ^ Miller, Robert (2023-05-30). "Faster Roche coronavirus test receives US Food and Drug Administration backing". The Times. ISSN 0140-0460. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
- ^ "Roche Annual General Meeting 2023". www.roche.com. Retrieved 2023-04-24.
- ^ Roland, Denise (2022-07-21). "Roche CEO Severin Schwan to Step Down Next Year". Wall Street Journal. ISSN 0099-9660. Archived from the original on 2023-05-30. Retrieved 2023-05-30.
- ^ "Innovation". Labor Berlin (in German). Archived from the original on 2023-04-24. Retrieved 2023-04-24.
- ^ "Roche CEO named as new president of IFPMA". www.thepharmaletter.com. Retrieved 2024-11-27.
- ^ Feldges, Dominik. "Thomas Schinecker tritt bei Roche ein schwieriges Erbe an". Neue Zürcher Zeitung (in Swiss High German). Archived from the original on 2023-04-24. Retrieved 2023-04-24.